Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Dr. Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Dr. Kidanu Hurisa Chachu,Network of Networks of HIV Positives in Ethiopia (NEP+), Ethiopia

Dr. Kidanu Hurisa Chachu is a seasoned Senior Public Health Specialist with over 16 years of extensive experience in the field. With a PhD in Public Health and advanced degrees in the same discipline, he has demonstrated leadership in managing national programs in HIV, TB, immunization, and environmental health. Currently serving as the Program Director at NEP+, he oversees strategic implementation across 300+ health facilities, coordinating community-based HIV care and psychosocial support. Previously, he served as a Technical Officer at UNDP, where he strengthened health and environment programs at the national level. His core strengths include project coordination, M&E, stakeholder engagement, data management, and advocacy. Dr. Kidanu is multilingual, fluent in English, Afan Oromo, and Amharic. His career is marked by data-driven decision-making, community impact, and successful partnerships with international donors, such as the Global Fund, UNAIDS, and PEPFAR.

Publication Profile

Google Scholar

πŸŽ“ Education

Dr. Kidanu holds a Doctor of Philosophy in Public Health from the University of South Africa (UNISA), where he is finalizing his doctoral research. His academic journey began with a Bachelor of Science in Public Health from Haramaya University in Ethiopia, completed in 2008. Driven by a passion for community health, he further pursued his Master’s degree in General Public Health from Wollega University, graduating in 2016. Throughout his academic path, Dr. Kidanu has focused on strengthening health systems, improving disease surveillance, and addressing public health challenges in resource-limited settings. His studies emphasize a strong foundation in research, statistical analysis, and results-based management, all of which are evident in his professional approach. His academic background has been essential to his leadership roles and to his ability to drive impactful, evidence-based public health interventions.

πŸ’Ό Experience

Dr. Kidanu currently leads NEP+ as Program Director, overseeing HIV response strategies across Ethiopia. He manages over 600 adherence supporters and leads national initiatives like Community-Led Monitoring (CLM), economic empowerment, and mother support groups. Prior to NEP+, he served as Technical Officer at UNDP (2021–2024), providing strategic and technical guidance on health and environment programs. There, he collaborated with the Ministry of Health and Environmental Protection Authority to improve project outcomes, mobilize resources, and manage donor-funded initiatives. His earlier experience spans clinical practice, research, and M&E roles that focused on HIV, TB, immunization, and environmental health. Dr. Kidanu’s hands-on experience in fieldwork, stakeholder engagement, and donor coordination reflects his dedication to delivering sustainable public health outcomes and system strengthening across Ethiopia.

πŸ… Awards and Honors

While specific awards are not explicitly listed, Dr. Kidanu’s career achievements reflect recognition at both national and international levels. At NEP+, he led the successful scale-up of key initiatives including Community-Led Monitoring and economic empowerment programs for PLHIV, achievements often recognized by partner institutions and donors. His leadership has enhanced Ethiopia’s HIV treatment adherence and digital M&E systems. At UNDP, his work contributed to policy development and was praised for aligning with SDG targets and donor expectations, particularly in collaboration with the EU and MoH. His consistent success in grant writing, program reporting, and stakeholder coordination underscores a highly commendable career. His track record suggests recognition through internal promotions, project expansions, and trusted leadership in donor-funded programs, affirming his status as a key figure in Ethiopia’s public health sector.

πŸ”¬ Research Focus

Dr. Kidanu’s research focus centers on health systems strengthening, monitoring and evaluation (M&E), and community-led HIV interventions. His doctoral work at UNISA contributes to the evidence base for improving adherence support, stigma reduction, and access to treatment in Ethiopia. His academic and field research explore the intersections of public health, environmental factors, and chronic disease management. He emphasizes participatory approaches, particularly Community-Led Monitoring (CLM), to generate real-time data and inform policy. Additionally, he’s contributed to studies involving maternal and child health, digital health systems, and the socio-economic empowerment of PLHIV. His evidence-driven strategies are reflected in national programs that integrate research findings into scalable interventions. His work contributes to global dialogues on sustainable HIV responses and health equity in low-resource settings.

Publication Top Notes

πŸ“˜ Prevalence and Factors Associated with Current Cigarette Smoking among Ethiopian University Students: A Systematic Review and Meta‐Analysis – Journal of Addiction – Cited by: 21 – Year: 2020 πŸ”πŸš¬πŸ“Š
πŸ“˜ Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia – HIV Medicine – Cited by: 0 – Year: 2025 πŸ§¬πŸ“ˆπŸ‘₯
πŸ“˜ Viral suppression among patients in HIV/AIDS care at healthcare facilities in Ethiopia: Same-day antiretroviral initiation – PLOS ONE – Cited by: 0 – Year: 2025 πŸ’ŠπŸ“‰πŸ₯
πŸ“˜ Retention of patients in HIV/AIDS care at the healthcare facility level in Ethiopia: Same-day antiretroviral initiation status – Unspecified Journal – Cited by: 0 – Year: 2024 πŸ₯πŸ”„πŸ§ͺ
πŸ“˜ Same-day antiretroviral therapy initiation and its association with viral suppression and retention in HIV care in Ethiopia – University of South Africa (Thesis) – Cited by: 0 – Year: 2024 πŸŽ“πŸ“šπŸ“‰
πŸ“˜ Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia – HIV Medicine (duplicate) – Cited by: 0 – Year: 2025 πŸ”πŸ“ŠπŸ§¬

Sylvia Kusemererwa | Public Health | Best Researcher Award

Dr. Sylvia Kusemererwa | Public Health | Best Researcher Award

Dr. Sylvia Kusemererwa, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Uganda

Dr. Sylvia Kusemererwa is a distinguished Scientist A, Project Leader, and Principal Investigator at MRC/UVRI & LSHTM Uganda Research Unit. She holds an MBChB and MPH from Makerere University and has extensive experience in clinical research, epidemiology, and infectious disease management. Dr. Kusemererwa has led multiple clinical trials on HIV prevention, malaria vaccines, and COVID-19 research. She actively contributes to national health policies, serving as Chair of the Masaka Regional Referral Hospital Research Ethics Committee. Her work has significantly impacted public health in Uganda and beyond. πŸ“

Publication Profile

Orcid

πŸŽ“ Education

Dr. Kusemererwa earned her MBChB (2001) and MPH (2010) from Makerere University, equipping her with expertise in public health and clinical research. She pursued specialized training in project management (PRINCE2), global health leadership (Afya Bora Fellowship), and research ethics. She has completed advanced courses in statistics, epidemiology, and scientific manuscript writing. Her certifications include GCP from LSHTM and Citiprogram HSP. Her continuous learning reflects her dedication to high-quality clinical trials and ethical research governance. πŸ“š

πŸ‘©β€βš•οΈ Experience

Dr. Kusemererwa has held key positions, including Scientist A at MRC Uganda, Clinical Coordinator at TASO Mbale, and Medical Officer at Kampala Medical Chambers. She has been a Principal Investigator and Study Coordinator for numerous trials on HIV vaccines, COVID-19, and malaria. Her leadership in clinical research spans over two decades, significantly advancing Uganda’s infectious disease research landscape. She also mentors researchers and chairs ethics committees, ensuring adherence to international research standards. πŸ₯

πŸ† Awards & Honors

Dr. Kusemererwa has been recognized for her contributions to public health and research ethics. She is Chair of the Masaka Regional Referral Hospital Research Ethics Committee and a mentor in the MRC-CTU Mentorship Scheme. She has received fellowships in global health leadership and numerous accolades for her role in advancing vaccine research and ethical clinical trials in Uganda. Her commitment to scientific excellence has established her as a leader in biomedical research. 🌍

πŸ”¬ Research Focus

Dr. Kusemererwa specializes in clinical trials for infectious diseases, focusing on HIV prevention, malaria vaccines, and emerging infections like COVID-19. She has led Phase 2 and 3 trials on HIV PrEP, vaccine efficacy, and maternal immunization. Her research emphasizes public health impact, implementation science, and ethical considerations in clinical studies. She collaborates globally to optimize vaccine deployment and improve healthcare interventions in sub-Saharan Africa. πŸ§ͺ

Publication Top Notes

  • “Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda” (2021)

  • “Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda” (2022)

  • “Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis” (2024)

  • “Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda” (2023)

  • “Contraceptive Preference Among Women at Risk of HIV Acquisition in Southwestern Uganda” (2018)